In addition, depending on the specific characteristics of the individual tumor, adjuvant therapy comprising systemic treatment with chemotherapy, endocrine therapy, anti-HER2 treatment and/or zoledronic acid, and postoperative radiation therapy are recommended to reduce the risk of relapse [5]. This evidence concerns the gene ERBB2 and neoplasm.